The FDA updated its list of breakthrough devices as medtech groups lobby for faster Medicare coverage of products with the designation.

Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.

The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.